Schede di attività / 2012 - CPO

Epidemiologia clinicaCentro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica in PiemonteScheda: 5.016• Zohar S, Baldi I, Forni G, Merletti F, Masucci G, Gregori D. Planning a Bayesian early-phase phase I/II studyfor human vaccines in HER2 carcinomas. Pharm Stat 2011;10:218-26.• Bo S, Cassader M, Cavallo-Perin P, Durazzo M, Rosato R, Gambino R. The rs553668 polymorphism of theADRA2A gene predicts the worsening of fasting glucose values in a cohort of subjects without diabetes. Apopulation-based study. Diabet Med 2012;29:549-52.• Gregori D, Petrinco M, Bo S, Desideri A, Merletti F, Pagano E. Regression models for analyzing costs and theirdeterminants in health care: an introductory review. Int J Qual Health Care 2011;23:331-41.• Gregori D, Petrinco M, Bo S, Rosato R, Pagano E, Berchialla P, Merletti F. Using data mining techniques inmonitoring diabetes care. The simpler the better? J Med Syst 2011;35:277-81.• Pagano E, De Rota B, Ferrando A, Petrinco M, Merletti F, Gregori D. An economic evaluation of water birth:the cost-effectiveness of mother well-being. J Eval Clin Pract 2010;16:916-9.• Bigi R, Ferrando A, Pagano E, Cortigiani L, Merletti F, Fiorentini C, Gregori D. Impact of advanced exerciseECG analysis on cost of coronary artery disease management. J Eval Clin Pract 2010;16:678-84.• Gianino MM, Petrinco M, Ferrando A, Galzerano M, Gregori D, Pagano E. [Methodological aspects in valuingloss of production and informal care in cost-of-illness studies]. Epidemiol Prev 2009;33:243-7.• Palumbo A, Bringhen S, Rossi D, Cavalli M, Larocca A, Ria R, Offidani M, Patriarca F, Nozzoli C, Guglielmelli T,Benevolo G, Callea V, Baldini L, Morabito F, Grasso M, Leonardi G, Rizzo M, Falcone AP, Gottardi D, MontefuscoV, Musto P, Petrucci MT, Ciccone G, Boccadoro M. Bortezomib-melphalan-prednisone-thalidomide followed bymaintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initialtreatment of multiple myeloma: a randomized controlled trial. J Clin Oncol 2010;28:5101-9.• Stratta P, Canavese C, Ciccone G, Rosso S. Relative survival of patients with lupus nephritis significantlyimproved over time in an Italian region: comment on the article by Faurschou et al. Arthritis Care Res(Hoboken) 2010;62:1812-3.• Stratta P, Mesiano P, Campo A, Colla L, Fop F, Ciccone G. Atherosclerosis in systemic lupus: the role ofantiphospholipid antibodies needs strict diagnostic criteria to be evaluated. Comment on the article by Urowitzet al. Arthritis Care Res (Hoboken) 2011;63:173-4;• Bo S, Ciccone G, Durazzo M, Ghinamo L, Villois P, Canil S, Gambino R, Cassader M, Gentile L, Cavallo-Perin P.Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohort.Int J Obes (Lond). 2011 Feb 1. [Epub ahead of print] PubMed PMID: 21285941.• Busca A, Locatelli F, Flonta SE, Ciccone G, Baldi I, D'Ardia S, Allione B, Falda M. In vivo T-cell depletion withpretransplant low-dose antithymocyte globulin is associated with reduced transplant-related mortality andimprobe clinical outcome in patients receiving allogeneic hematopoietic stem cell transplantation fromunrelated and partially matched related donors. Am J Hematol. 2011 Feb;86(2):214-7. doi: 10.1002/ajh.21907.Epub 2010 Nov 30. PubMed PMID: 21264911.• Giaccone L, Storer B, Patriarca F, Rotta M, Sorasio R, Allione B, Carnevale-Schianca F, Festuccia M, BrunelloL, Omedè P, Bringhen S, Aglietta M, Levis A, Mordini N, Gallamini A, Fanin R, Massaia M, Palumbo A, Ciccone G,Storb R, Gooley TA, Boccadoro M, Bruno B. Long-term follow up of a comparison of non-myeloablativeallografting with autografting for newly diagnosed myeloma. Blood. 2011 Apr 13. [Epub ahead of print]PubMed PMID: 21490341.• Mongini F, Evangelista A, Rota E, Ferrero L, Ugolini A, Milani C, Ceccarelli M, Joffrain L, Ciccone G, Galassi C.Further evidence of the positive effects of an educational and physical program on headache, neck andshoulder pain in a working community. J Headache Pain. 2010 Oct;11(5):409-15. Epub 2010 Jun 20. PubMedPMID: 20563879.• Palumbo A, Bringhen S, Rossi D, Cavalli M, Larocca A, Ria R, Offidani M, Patriarca F, Nozzoli C, Guglielmelli T,Benevolo G, Callea V, Baldini L, Morabito F, Grasso M, Leonardi G, Rizzo M, Falcone AP, Gottardi D, MontefuscoV, Musto P, Petrucci MT, Ciccone G, Boccadoro M. Bortezomib-melphalan-prednisone-thalidomide followed bymaintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initialtreatment of multiple myeloma: a randomized controlled trial. J Clin Oncol. 2010 Dec 1;28(34):5101-9.• Rota E, Evangelista A, Ciccone G, Ferrero L, Ugolini A, Milani C, Ceccarelli M, Galassi C, Mongini F.Effectiveness of an educational and physical program in reducing accompanying symptoms in subjects withhead and neck pain: a workplace controlled trial. J Headache Pain. 2011 Jan 20. [Epub ahead of print] PubMedPMID: 21249417.• Palumbo A, Bringhen S, Bruno B, Falcone AP, Liberati AM, Grasso M, Ria R, Pisani F, Cangialosi C, Caravita T,Levi A, Meloni G, Nozza A, Pregno P, Gabbas A, Callea V, Rizzo M, Annino L, De Stefano V, Musto P, Baldi I,Cavallo F, Petrucci MT, Massaia M, Boccadoro M. Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) innewly diagnosed myeloma patients: a prospective, multicenter phase 3 study. Blood 2010;115:1873-9.• Fracchia M, Senore C, Armaroli P, Ferraris R, Placido RD, Musso A, Turco D, Bellisario C, Baldi I, Segnan N.Assessment of the multiple components of the variability in the adenoma detection rate in sigmoidoscopyscreening, and lessons for training. Endoscopy 2010. [Epub ahead of print] PubMed PMID: 20414864.• Terragni PP, Antonelli M, Fumagalli R, Faggiano C, Berardino M, Pallavicini FB, Miletto A, Mangione S, SinardiAU, Pastorelli M, Vivaldi N, Pasetto A, Della Rocca G, Urbino R, Filippini C, Pagano E, Evangelista A, Ciccone G,Mascia L, Ranieri VM. Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adultICU patients: a randomized controlled trial. JAMA 2010;303:1483-9.• Berruti A, Bollito E, Cracco CM, Volante M, Ciccone G, Porpiglia F, Papotti M, Scarpa RM, Dogliotti L. Theprognostic role of immunohistochemical chromogranin a expression in prostate cancer patients is significantlymodified by androgen-deprivation therapy. Prostate 2010;70:718-26.• Bo S, Gambino R, Gentile L, Pagano G, Rosato R, Saracco GM, Cassader M, Durazzo M, Cavallo-Perin P.High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: apopulation-based study. J Hypertens 2009;27:102-8.• Baldi I, Maule M, Bigi R, Cortigiani L, Bo S, Gregori D. Some notes on parametric link functions in clinical216